stella
beta
Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors — Stella
Recruiting
Back to Unresectable trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
Shandong Cancer Hospital & Institute, Jinan, Shandong
View full record on ClinicalTrials.gov